Includes all AIM, ASX, CBOE, CSE, LSE, TSX and TSXV companies with US symbols
Loading...
Get Featured
OTCQB

SEOVFSERNOVA BIOTHERAPEUTICS INC.

Loading price...
Loading price changes...
Loading market cap...

Price Chart

Loading chart...

About SERNOVA BIOTHERAPEUTICS INC. (SEOVF)

SERNOVA BIOTHERAPEUTICS INC. (SEOVF) is a Biotechnology company headquartered in London, ON, Canada whose shares trade over-the-counter on the OTCQB tier.

Sernova Corp. is a cell therapeutics company, focused on developing and commercializing its proprietary implantable prevascularized medical device technologies: the Cell PouchTM and associated technologies including therapeutic cells and local immune protection. The Cell Pouch is a scalable, implantable, medical device, designed to create a microvessel rich, tissue environment for the transplantation and engraftment of therapeutic cells. These cells, following transplantation into the implanted device vascularized environment, release proteins, hormones or other factors into the bloodstream for the long-term treatment of a number of serious, chronic diseases such as diabetes, hemophilia and thyroid disease.

Products and services

Sernova is developing a cell therapeutics technology platform, consisting of an implantable medical device and immune protected therapeutic cells (i.e. human donor cells, corrected human cells and stem cell-derived cells), to improve the treatment for and quality of life of people with chronic metabolic diseases such as insulin-dependent diabetes, thyroid disease, blood disorders including hemophilia A, and other diseases treated through replacement of proteins or hormones missing or in short supply within the body.

SEOVF key facts

Ticker symbol
SEOVF
Market tier
OTCQB
Headquarters
London, ON, Canada
Country of incorporation
CA
Year of incorporation
1998
Employees
16
Estimated market cap
$46.53M (as of Apr 17, 2025)
Shares outstanding
327,199,786
Reporting standard
International Reporting: Toronto Stock Exchange
Audit status
Audited
Fiscal year end
10/31
Latest filing
Annual Report (Oct 31, 2024)

SERNOVA BIOTHERAPEUTICS INC. leadership

  • David Burke — VP, Investor Rel.
  • Marie Kaldchibachi — Director, Fin.
  • Accounts Payable — Other

Explore more: Biotechnology stocks · Healthcare sector · OTCQB stocks · OTC stocks starting with S

Press Releases

Loading press releases...

Latest News

Loading news...

SPONSORED
Loading ads...
SPONSORED
Loading ads...

Key Statistics

Major Holders

Loading...

Loading modules...

AI-Powered Stock Analysis

Get a concise 600-word investment analysis for SERNOVA BIOTHERAPEUTICS INC. (SEOVF) prioritizing the most recent news and developments. Our AI focuses on today's breaking news first, then recent company developments, business updates, strategic initiatives, and current market positioning. Get the most relevant and current analysis available.

Still in beta - Please send feedback after generating your analysis to help us improve!

Smart investment analysis prioritizing breaking news, then recent company developments and strategic insights - completely free!

By submitting, you agree to our Privacy Policy and Terms of Service. We'll add you to our newsletter but you can unsubscribe at any time.

Investor Reviews

Investor Reviews (0)

Loading reviews...

Get Verified

Is this your company?

Get verified and take control of your company page. Add your verified badge, edit information, and showcase your business to investors.

Low Cost
Quick Setup
SPONSORED
Loading ads...
SPONSORED
Loading ads...
SPONSORED
Loading ads...
SPONSORED
Loading ads...

Company Profile

Loading company profile data...

Contact Information

Investor Relations Email
Not provided
Headquarters Address
700 Collip Circle,
London, ON, N6G 4X8
Canada

Company Leadership

Company Officers

David Burke
VP, Investor Rel.
Marie Kaldchibachi
Director, Fin.
Accounts Payable
Other

Social Media

Business Details

Stock Details

Loading modules...